Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Igor Elman

Showing results (21-30 of 147) with videos related to

Pageof 15
Sort By:
The American Journal of Drug and Alcohol Abuse|May 8, 2020
Reduced cigarette smoking during injectable extended-release naltrexone treatment for opioid use disorderAn-Li Wang, Zhenhao Shi, Igor Elman, et al.
Human Psychopharmacology|June 3, 2017
Oral glucose tolerance test performance in olanzapine-treated schizophrenia-spectrum patients is predicted by BMI and triglycerides but not olanzapine dose or durationJeffrey Guina, Sayon Roy, Ankur Gupta, et al.
Psychopharmacology|October 1, 2011
Depot naltrexone decreases rewarding properties of sugar in patients with opioid dependenceDaniel D Langleben, Elliot L Busch, Charles P O'Brien, et al.
Plos One|June 26, 2009
Gender differences in the motivational processing of babies are determined by their facial attractivenessRinah Yamamoto, Dan Ariely, Won Chi, et al.
Journal of Behavioral Addictions|March 10, 2017
Post-traumatic stress symptoms in pathological gambling: Potential evidence of anti-reward processesCheryl L Green, Ramzi W Nahhas, Arielle A Scoglio, et al.
Pain|September 21, 2018
When pain gets stuck: the evolution of pain chronification and treatment resistanceDavid Borsook, Andrew M Youssef, Laura Simons, et al.
Journal of Addictive Diseases|March 31, 2024
Blood pressure response to extended-release naltrexone in heroin and prescription opioid users and its implications for cardiovascular morbidityZhenhao Shi, Daniel D Langleben, David Rott, et al.
Neuroscience and Biobehavioral Reviews|February 25, 2018
Subliminal (latent) processing of pain and its evolution to conscious awarenessDavid Borsook, Andrew M Youssef, Nadia Barakat, et al.
Frontiers in Neuroscience|January 4, 2021
Mechanisms Underlying Unconscious Processing and Their Alterations in Post-traumatic Stress Disorder: Neuroimaging of Zero Monetary Outcomes Contextually Framed as "No Losses" vs. "No Gains"Igor Elman, Jaymin Upadhyay, Steven Lowen, et al.
Plos One|February 10, 2012
Yohimbine-induced amygdala activation in pathological gamblers: a pilot studyIgor Elman, Lino Becerra, Evelyne Tschibelu, et al.
Pageof 15

Showing results (21-30 of 147) with videos related to

Sort By:
Pageof 15
The American Journal of Drug and Alcohol Abuse|May 8, 2020
Reduced cigarette smoking during injectable extended-release naltrexone treatment for opioid use disorderAn-Li Wang, Zhenhao Shi, Igor Elman, et al.
Human Psychopharmacology|June 3, 2017
Oral glucose tolerance test performance in olanzapine-treated schizophrenia-spectrum patients is predicted by BMI and triglycerides but not olanzapine dose or durationJeffrey Guina, Sayon Roy, Ankur Gupta, et al.
Psychopharmacology|October 1, 2011
Depot naltrexone decreases rewarding properties of sugar in patients with opioid dependenceDaniel D Langleben, Elliot L Busch, Charles P O'Brien, et al.
Plos One|June 26, 2009
Gender differences in the motivational processing of babies are determined by their facial attractivenessRinah Yamamoto, Dan Ariely, Won Chi, et al.
Journal of Behavioral Addictions|March 10, 2017
Post-traumatic stress symptoms in pathological gambling: Potential evidence of anti-reward processesCheryl L Green, Ramzi W Nahhas, Arielle A Scoglio, et al.
Pain|September 21, 2018
When pain gets stuck: the evolution of pain chronification and treatment resistanceDavid Borsook, Andrew M Youssef, Laura Simons, et al.
Journal of Addictive Diseases|March 31, 2024
Blood pressure response to extended-release naltrexone in heroin and prescription opioid users and its implications for cardiovascular morbidityZhenhao Shi, Daniel D Langleben, David Rott, et al.
Neuroscience and Biobehavioral Reviews|February 25, 2018
Subliminal (latent) processing of pain and its evolution to conscious awarenessDavid Borsook, Andrew M Youssef, Nadia Barakat, et al.
Frontiers in Neuroscience|January 4, 2021
Mechanisms Underlying Unconscious Processing and Their Alterations in Post-traumatic Stress Disorder: Neuroimaging of Zero Monetary Outcomes Contextually Framed as "No Losses" vs. "No Gains"Igor Elman, Jaymin Upadhyay, Steven Lowen, et al.
Plos One|February 10, 2012
Yohimbine-induced amygdala activation in pathological gamblers: a pilot studyIgor Elman, Lino Becerra, Evelyne Tschibelu, et al.
Pageof 15